TRPV1 and neuropathy: This is the first study to describe sensitization of TRPV1 and TRPA1 and/or TRPM8 in a model of oxaliplatin induced neuropathy, the role of cAMP in mediating the sensitization, and the effectiveness of a CB2 agonist in mitigating it.